346 related articles for article (PubMed ID: 18468382)
1. Pharmaceutical GMP: past, present, and future--a review.
Patel KT; Chotai NP
Pharmazie; 2008 Apr; 63(4):251-5. PubMed ID: 18468382
[TBL] [Abstract][Full Text] [Related]
2. [Pharmaceutical product quality control and good manufacturing practices].
Hiyama Y
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):1-16. PubMed ID: 21381389
[TBL] [Abstract][Full Text] [Related]
3. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
WHO Expert Committee on Specifications for Pharmaceutical Preparations
World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
[TBL] [Abstract][Full Text] [Related]
4. WHO Expert Committee on specifications for pharmaceutical preparations.
World Health Organization Expert Committee
World Health Organ Tech Rep Ser; 2010; (957):1-276, back cover. PubMed ID: 20560300
[TBL] [Abstract][Full Text] [Related]
5. The regulatory framework for preventing cross-contamination of pharmaceutical products: History and considerations for the future.
Sargent EV; Flueckiger A; Barle EL; Luo W; Molnar LR; Sandhu R; Weideman PA
Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S3-S10. PubMed ID: 27230736
[TBL] [Abstract][Full Text] [Related]
6. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organization
World Health Organ Tech Rep Ser; 2011; (961):1-428, back cover. PubMed ID: 21699061
[TBL] [Abstract][Full Text] [Related]
7. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organization
World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
[TBL] [Abstract][Full Text] [Related]
8. Highlights of Good Manufacturing Practice in Japan.
Morita K
J Parenter Sci Technol; 1990; 44(1):35-8. PubMed ID: 2313491
[TBL] [Abstract][Full Text] [Related]
9. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
[TBL] [Abstract][Full Text] [Related]
10. Developing a tool for the preparation of GMP audit of pharmaceutical contract manufacturer.
Linna A; Korhonen M; Mannermaa JP; Airaksinen M; Juppo AM
Eur J Pharm Biopharm; 2008 Jun; 69(2):786-92. PubMed ID: 18191391
[TBL] [Abstract][Full Text] [Related]
11. Good manufacturing practice for immunological veterinary medicinal products.
Todd JI
Rev Sci Tech; 2007 Apr; 26(1):135-45. PubMed ID: 17633298
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between pharmaceutical industry and the French government during the last two centuries].
Bonnemain H; Bonnemain B
Rev Hist Pharm (Paris); 2002; 50(334):239-56. PubMed ID: 12378715
[TBL] [Abstract][Full Text] [Related]
13. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
[TBL] [Abstract][Full Text] [Related]
14. Vendor qualification for pharmaceutical excipients--GMP requirements and approach.
Patel KT; Chotal NP
Pharmazie; 2010 Nov; 65(11):783-90. PubMed ID: 21155382
[TBL] [Abstract][Full Text] [Related]
15. Some interpretations of controversial sub-sections in the Current Good Manufacturing Practice regulations for drug products.
Loftus BT
J Parenter Drug Assoc; 1979; 33(6):326-32. PubMed ID: 261583
[No Abstract] [Full Text] [Related]
16. The 1941 sulfathiazole disaster and the birth of good manufacturing practices.
Swann JP
Pharm Hist; 1999; 41(1):16-25. PubMed ID: 11623769
[No Abstract] [Full Text] [Related]
17. [Pharmaceutical quality and good manufacturing practices (author's transl)].
Traisnel
J Pharm Belg; 1980; 35(3):233-7. PubMed ID: 7400928
[No Abstract] [Full Text] [Related]
18. [Changes in the norms governing practices for the manufacture of pharmaceutical products: implications for the MERCOSUR].
Temprano G; Prats S; Bregni C
Boll Chim Farm; 1998 Nov; 137(10):426-38. PubMed ID: 9880947
[TBL] [Abstract][Full Text] [Related]
19. Specifications from a biotechnology industry perspective.
Garnick RL
Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
[TBL] [Abstract][Full Text] [Related]
20. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
